Auditory testing outcomes with hearing aids in patients with auditory neuropathy spectrum disorder.


Journal

American journal of otolaryngology
ISSN: 1532-818X
Titre abrégé: Am J Otolaryngol
Pays: United States
ID NLM: 8000029

Informations de publication

Date de publication:
Historique:
received: 23 03 2021
accepted: 10 04 2021
pubmed: 24 4 2021
medline: 15 12 2021
entrez: 23 4 2021
Statut: ppublish

Résumé

The objective of this study is to evaluate the audiologic outcomes with hearing aids in pediatric patients with auditory neuropathy spectrum disorder (ANSD) using the Infant Toddler-Meaningful Auditory Integration Scale (IT-MAIS), and the Ling 6 Sound Test (Ling 6). Case series. Single tertiary care academic medical center. All pediatric patients with a confirmed diagnosis of ANSD on Auditory Brainstem Response (ABR) testing who presented to a single tertiary medical center between September 2008 and September 2018 were included. Only patients that underwent Infant Toddler-Meaningful Auditory Integration Scale (IT-MAIS) and/or Ling 6 Sound Test (Ling 6) were included in the study. Audiologic testing performed after cochlear implantation was excluded. 60 pediatric patients with ANSD were analyzed. There were 10 patients included in the study with documented hearing aid use who underwent IT-MAIS and/or Ling 6 testing. Average IT-MAIS score improved by 20.4% after initial or extended trial of amplification. Similarly, average Ling 6 score improved from 3.6 to 4.8 after initial or extended trial of amplification. The four patients who did not receive amplification had higher average IT-MAIS and Ling 6 scores. In most children with ANSD, IT-MAIS and Ling 6 Sound Test scores improved with initial hearing aid use and over time with extended hearing aid use. Long-term prospective, multi-institutional studies are needed to determine the impact of the natural history of ANSD, comorbidities, and socioeconomic variables on auditory function testing results in children with ANSD using hearing aids.

Identifiants

pubmed: 33892226
pii: S0196-0709(21)00158-7
doi: 10.1016/j.amjoto.2021.103057
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103057

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Firas Sbeih (F)

Cleveland Clinic Foundation, Head and Neck Institute, USA.

Donald M Goldberg (DM)

Cleveland Clinic Foundation, Head and Neck Institute, USA; College of Wooster, USA.

Sara Liu (S)

Cleveland Clinic Foundation, Head and Neck Institute, USA.

Maxwell Y Lee (MY)

Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, USA.

Gina Stillitano (G)

Cleveland Clinic Foundation, Head and Neck Institute, USA.

Swathi Appachi (S)

Cleveland Clinic Foundation, Head and Neck Institute, USA.

Samantha Anne (S)

Cleveland Clinic Foundation, Head and Neck Institute, USA. Electronic address: annes@ccf.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH